patient.mirvaso.be
MIR - Live Web 02 - Default - IndexThis is a holding page to ensure that the Load Balancer believes the server to be healthy.
http://patient.mirvaso.be/
This is a holding page to ensure that the Load Balancer believes the server to be healthy.
http://patient.mirvaso.be/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
1 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
2
SITE IP
54.194.189.101
LOAD TIME
1.031 sec
SCORE
6.2
MIR - Live Web 02 - Default - Index | patient.mirvaso.be Reviews
https://patient.mirvaso.be
This is a holding page to ensure that the Load Balancer believes the server to be healthy.
Welcome to our Patient Portal
We now provide you with 24/7 electronic access to:. View and manage your medical records. Exchange secure messages with our staff. Sign in with your Account. Having trouble with your login? Don’t have an account yet?
Login
MeeDoc
MERMS - User
MIR - Live Web 02 - Default - Index
This is a holding page to ensure that the Load Balancer believes the server to be healthy.
English
This site is for Patients. Information for Patients prescribed with Mirvaso. Mirvaso is a gel that is applied to the face when a person wishes to reduce the appearance of facial redness due to rosacea. It contains an active ingredient, brimonidine. What is Mirvaso for? Mirvaso is used to reduce the appearance of facial redness due to rosacea. Redness can be reduced 30 minutes after application and the effects can last up to 12 hours. How does Mirvaso work? How long does Mirvaso take to work? Consult your...
MIR - Live Web 01 - Default - Index
This is a holding page to ensure that the Load Balancer believes the server to be healthy.
Start your secure, online dermatology visit here
Last Built: 12/9/2016, 2:38:50 PM.
Carestream Vue Motion
INLOGGEN PATIENTEN - MSenactie
Patiënten, familie en vrienden. Patiënten met medicatie van Novartis. Vul hier uw inlogcode in:. De EU-code treft u aan op uw Gilenya verpakking. Uw toegang tot en gebruik van deze site is onderworpen aan onze disclaimer. 2013 Novartis Pharma B.V.
